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Abstract
Potential adverse effects of excess maternal folic acid supplementation on a vegetarian population deficient in vitamin B12
are poorly understood. We have previously shown in a rat model that maternal folic acid supplementation at marginal
protein levels reduces brain omega-3 fatty acid levels in the adult offspring. We have also reported that reduced
docosahexaenoic acid (DHA) levels may result in diversion of methyl groups towards DNA in the one carbon metabolic
pathway ultimately resulting in DNA methylation. This study was designed to examine the effect of normal and excess folic
acid in the absence and presence of vitamin B12 deficiency on global methylation patterns in the placenta. Further, the
effect of maternal omega 3 fatty acid supplementation on the above vitamin B12 deficient diets was also examined. Our
results suggest maternal folic acid supplementation in the absence of vitamin B12 lowers plasma and placental DHA levels
(p,0.05) and reduces global DNA methylation levels (p,0.05). When this group was supplemented with omega 3 fatty
acids there was an increase in placental DHA levels and subsequently DNA methylation levels revert back to the levels of the
control group. Our results suggest for the first time that DHA plays an important role in one carbon metabolism thereby
influencing global DNA methylation in the placenta.
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Introduction
In developing countries, micronutrient deficiencies such as folic
acid and vitamin B12 are common and associated with poor
pregnancy outcomes, having long term health effects. The peri or
post-conceptional period represents a sensitive window during
which suboptimal maternal micronutrients may affect feto-
placental development [1]. In view of this, maternal folic acid
supplementation is in operation for the last few decades in India.
This is regardless of the fact that there is still a poor knowledge
about potential adverse effects on a population mainly consuming
a vegetarian diet that may lack vitamin B12 [2]. Although early
results from the fortification policy indicate beneficial effects in
terms of reduction in plasma homocysteine [3–5], recent reports
suggest adverse effects in humans [6,7]. During growth high folic
acid administration has been shown to alter dietary protein
metabolism and to decrease fetal size, as compared to rats fed a
control diet [8]. It has also been reported recently, that high folate
intakes in vitamin B12 deficient mothers are shown to increase the
risk of type 2 diabetes in the offspring suggesting that defects in
one-carbon metabolism might be at the heart of intrauterine
programming of adult disease [9].
Our earlier studies in the rat model that maternal folic acid
supplementation at marginal protein levels reduces the levels of
brain essential polyunsaturated fatty acid levels especially omega 3
fatty acids in the offspring [10,11]. Ongoing studies in our lab have
also highlighted the importance of docosahexaenoic acid (an
omega 3 fatty acid) during pregnancy [12,13]. Docosahexaenoic
acid (DHA) is an indispensable component of all cell membranes
and is incorporated in high concentrations in the membrane
phospholipids of brain and retina [14] and its availability during
the perinatal period is shown to be associated with long term
cognitive and visual development [15,16].
It is well established that folate and vitamin B12 are the major
determinants of one carbon metabolism in which S-adenosyl
methionine (SAM) a methyl group donor is formed [17]. Dietary
folate is converted in the body to 5 methyl tetrahydrofolate (5-
MTHF) by the enzyme methylene tetrahydrofolate reductase
(MTHFR). The transfer of methyl group from 5-MTHF to
homocysteine requires vitamin B12 and results in the synthesis of
methionine. Methionine is the precursor for SAM. Methyl groups
from SAM are transferred by phosphatidyl ethanolamine–N–
methyltransferase (PEMT) to DHA and to DNA and histones by
the respective methyltransferases. Phosphatidylcholine (PC) is
critical for the delivery of important polyunsaturated fatty acids
(PUFA) such as docosahexaenoic acid from the liver to the plasma
and distribution to peripheral tissues. Fig. 1 shows the interactions
of folic acid, vitamin B12 and DHA. We have recently described
that when DHA levels are low, there will be less methyl group
requirement for conversion of PE-DHA to PC-DHA and may
result in excess methyl group availability for other trans-
methylation reactions such as DNA and histone methylation
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We therefore hypothesize that omega 3 fatty acids play a key role
in one carbon metabolism affecting global methylation levels.
Placenta is an organ whose proper development and function
are crucial to the health, growth, and survival of the developing
fetus. A number of studies are now making important links
between alterations to appropriate epigenetic regulation in the
placenta and diseases of gestation and early life [19]. Examining
epigenetic alterations in the placenta will prove especially
important in the search for biomarkers of exposure, pathology,
and disease risk and can provide critical insights into the biology of
development and pathogenesis of disease [20].
The present study therefore for the first time, examines the
effect of normal and excess folic acid in the absence and presence
of vitamin B12 deficiency on global methylation patterns in the
placenta. Further, the effect of maternal omega 3 fatty acid
supplementation on the above vitamin B12 deficient diets was also
examined.
Materials and Methods
This study was carried out in accordance with the CPCSEA
guidelines (Committee for the purpose of control and supervision
of experimental animals) Govt of India. This study was approved
by the Bharati Vidyapeeth Animal Ethical Committee (IAEC/
CPCSEA/258). The institute is recognized to undertake experi-
ments on animals as per the CPCSEA, Govt of India.
Animals
Wistar albino rats (60F, 20M) of average weight 150 g were
obtained from National Toxicology Center animal house. Instead
of using them directly for the experimental protocol it was thought
appropriate to use their progeny. They were maintained at 22uC
on a controlled 12-hr light and 12 hr dark cycle with appropriate
ventilation system. Animals were marked with picric acid as H
(head), Back (B), Tail (T) etc for identification.
Breeding
These pups were then put for breeding at 3 months of age.
Males were housed individually prior to mating to acquire cage
dominance. Virgin female rats were allowed to breed (sex ratio
1:3). On the following morning the vaginal smears were taken to
confirm mating. Vaginal smears were taken on a clean microscope
slide using a cotton bud dipped in saline. The slides were
examined under a microscope at 106 magnification. The sperm
positive smear was considered a result of successful mating and
considered day 0 of gestation. The pregnant dams were housed
individually (in polypropylene cages of 29622614 cm dimensions
containing rice husk as bedding material). Animals receiving
Vitamin B12 deficient diets were kept in special cages to prevent
coprophagy.
Out of 60 females, 47 females became pregnant and were
divided randomly into 6 dietary groups. All dams were delivered
by C section on day 20 of gestation.
Diets
The composition of the control and the treatment diets (Table 1)
was as per AIN 93 purified diets for laboratory rodents [21]. Protein
level in the control and treatment diets was 18%. Total of six
isocaloric treatment diets were formulated and has been described
by us recently [22,23]. Briefly four diets were formulated for
examiningthe effects of 2 differentlevels of folic acid (i.e2 and 8 mg
folic acid/kg diet) during pregnancy both in the presence and
absence of vitaminB12. In addition, 2 more diets wereformulated to
examine the effects of omega 3 fatty acid (DHA+EPA (Eicosapen-
taenoic acid)) supplementation on both the vitamin B12 deficient
groups. Vitamin B12 deficiency was obtained exclusively through
Figure 1. One-Carbon Cycle: Interactions of folic acid, vitamin B12 and DHA. THF- tetrahydrofolate; 5, 10-MTHF- 5, 10-
methylenetetrahydrofolate; 5-MTHF- 5-methyltetrahydrofolate; MTHFR- methylenetetrahydrofolate reductase; MS- methionone synthase; SAH- S-
adenosylhomocysteine; SAM- S-adenosylmethionine; DHA-docosahexanoic acid; PE-DHA- phosphatidylethanolamine-DHA; PC-DHA-phosphatidyl-
choline-DHA; PEMT- phosphatidylethanolamine-N-methyltransferase; DNMT- DNA methyltransferase; HMT- Histone methyltransferase; Q- reduced;
qq-increased.
doi:10.1371/journal.pone.0017706.g001
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Thus there were a total of 6 groups:
Control- normal folate, normal B12, NFBD- normal folate, B12
deficient, NFBDO-normal folate, B12 deficient, omega 3 supple-
mented, EFB- excess folate, normal B12, EFBD-excess folate,
B12 deficient, EFBDO- excess folate, B12 deficient, omega 3
supplemented.
The lowest level, i.e. 2 mg/kg represents the normal level of folic
acid used in the control diet as per the current AIN 93 guidelines
while 8 mg/kg is roughly 4 times the requirement of a normal rat.
This is in accordance with the fact that folic acid requirement for
Indian pregnant woman is set at 400 mg/d, which is 4 times the
requirement of a non-pregnant woman. The level of omega 3 fatty
acid supplementation was chosen to have an omega 6/omega 3
ratio of 1:1 which is considered to be the ideal ratio [24].
Observations recorded
During pregnancy, dam weights were recorded at day 0, 7, 14 &
20 to obtain weight gains. On day 20 of gestation the litter weight
and size was recorded in each group.
Maternal plasma folic acid, vitamin B12 and homocysteine
levels
Plasma vitamin B12 and plasma folic acid were measured using
a radioimmunoassay kit (Diagnostic Products Corporation, USA)
[25] and plasma total homocysteine was determined using the IMx
System (Abbott Laboratories, IL, USA) [26].
Tissue collection and processing
Dams were dissected at day 20 of gestation and placental tissues
were collected. Fetal membranes were trimmed off and the
placenta was weighed. Placentas were snap frozen and stored at
280uC until assayed.
Placental fatty acid levels
The procedure for fatty acid analysis used in our study was
revised from the original method of Manku et al. that has been
reported by us earlier in a separate study [27,28]. Briefly,
placental tissue was homogenized with chilled PBS and
centrifuged at 10000 rpm at 4uC for 20 min. Supernantant and
cell membrane fractions were separated. Transesterification of
cell membrane phospholipid fraction was carried out using
hydrochloric acid-methanol. These were separated using a Perkin
Elmer gas chromatograph (SP 2330, 30 m capillary Supelco
column. Helium was used as carrier gas at 1 mL/min. Oven
temperature was held at 150uC for 10 min, programmed to rise
from 150 to 220uCa t1 0 uC/min, and at 220uC for 10 min. The
detector temperature was 275uC and the injector temperature
was 240uC. Retention times and peak areas were automatically
computed. The column was calibrated by injecting the standard
fatty acid mixture in approximately equal proportion. The data
was recorded and the peaks were identified as per the retention
time of the standard fatty acids (Sigma) run under the identical
conditions. Fatty acids were expressed as g/100 g fatty acid.
Total of 15 fatty acids were detected. Saturated fatty acids
include myristic acid, palmitic acid and stearic acids, while total
monounsaturated fatty acids include myristoleic, palmitoleic,
oleic acid and nervonic acids. The omega 3 fatty acids included
alpha linolenic acid, eicosapentaenoic acid and docosahexaenoic
acid while total omega 6 fatty acids included linoleic acid, gamma
linolenic acid, di-homo-gammalinolenic acid, docosapentaenoic
acid and arachidonic acid.
Table 1. Composition of the diets.
S.No Diets Control (g/kg) NFBD (g/kg) EFB (g/kg) EFBD (g/kg) NFBDO (g/kg) EFBDO (g/kg)
1. Corn Starch 398 398 398 398 398 398
2. Casein 200 200 200 200 200 200
3. Dextrinized Starch 132 132 132 132 132 132
4. Sucrose 100 100 100 100 100 100
5. Soya Bean Oil 70 70 70 70 25 25
6 Fish oil 0 0 0 0 45 45
7. Fiber 50 50 50 50 50 50
8. Mineral mixture
* 35 35 35 35 35 35
9 Vitamin mixture
{ 10 10 10 10 10 10
Folic acid 0.002 0.002 0.008 0.008 0.002 0.008
Vitamin B12 0.025 0 0.025 0 0 0
10 Cystine 3 3 3 3 3 3
11. Choline Bitartarate 2.5 2.5 2.5 2.5 2.5 2.5
12. Tertiary Butyl Hydroquinone 0.014 0.014 0.014 0.014 0.014 0.014
Total Energy (kJ) 1.57 1.57 1.57 1.57 1.57 1.57
*Mineral mixture (g/kg mixture):Calcium carbonate, 357; Potassium Phosphate, 196; Potassium Citrate, 70.78; Sodium Chloride, 78; Potassium Sulphate, 46.6;
Magnesium Oxide, 24; Ferric Citrate, 6.06; Zinc Carbonate, 1.65; Manganous Carbonate, 0.63; Cupric Carbonate, 0.3; Potassium Iodate, 0.01; Sodium Selenate, 0.01;
Ammonium Paramolybdate, 0.007; Sodium Metasilicate, 1.45; Chromium Potassium Sulphate, 0.275; Lithium Chloride, 0.01; Boric Acid, 0.08; Sodium Fluoride, 0.06;
Nickel Carbonate, 0.03; Ammonium Vanadate, 0.006; Sucrose, 221.02.
{Vitamin mixture (g/kg mixture):Nicotinic Acid, 3; Calcium Pantothenate, 1.6; Pyridoxine-HCl, 0.7; Thiamin –HCl, 0.6; Riboflavin, 0.6; D-Biotin, 0.02; Vitamin B12 (in
0.1% Mannitol), 2.5;Vitamin E, 15;Vitamin A, 0.8; Vitamin D-3, 0.25;Vitamin K, 0.075;Folic acid, 0.2 (control) and Sucrose 974.655, was used to make total weight of the
vitamin mixture to 1 kg.
Control: Normal folate, normal B12, NFBD: normal folate, B12 deficient, NFBDO: normal folate, B12 deficient, omega 3 supplemented, EFB: Excess folate, normal B12,
EFBD: Excess folate, B12 deficient, EFBDO: Excess folate, B12 deficient, omega 3 supplemented.
doi:10.1371/journal.pone.0017706.t001
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Genomic DNA extraction from placental tissues was carried out
with the Qiagen Blood and Tissue kit. Global DNA methylation
was measured using the Methylamp
TM Global DNA Methylation
Quantification Kit (Epigentek Group Inc., New York, NY, U.S.A.)
as we have described recently [29]. The kit yields accurate
measures of methylcytosine content as a percentage of total
cytosine content.
The methodology for estimation of global methylation levels
used in this study takes into account methylation of all CpG’s
irrespective of their position in the genome (promoter and non-
promoter CpG). This is in concurrence with studies indicating that
CpG methylation in intragenic and intergenic regions are also
critical to gene expression [30].
Statistical Analysis
Litter means were used as the unit of analysis. Values are mean
6 SD. The data were analyzed using SPSS/PC+ package (Version
11.0, Chicago IL). The treatment groups were compared with the
control group by ANOVA and the post-hoc least significant
difference test.
Results
Feed intake
Feed intake during pregnancy was between 15–19 g/day.
There was no effect of different levels of folic acid both in the
presence and absence of vitamin B12 on feed intake. In contrast,
feed intake in both the omega 3 fatty acid supplemented groups
was lower (p,0.01) than control. Further feed intake in omega 3
fatty acid supplemented groups were also lower than those in their
respective B12 deficient groups (NFBD Vs NFBDO, p,0.05) and
(EFBD Vs EFBDO, p,0.05) and has been reported by us recently
[23].
Reproductive performance
There was no effect of folic acid supplementation in the
presence of vitamin B12 (EFB) on weight gain of dams as compared
to control during pregnancy. There was also no difference in
weight gain in the dams fed omega 3 fatty acids as compared to
control or any of the other treatment groups. The pup weight
between groups was comparable and has been reported by us
recently[23].
Maternal plasma folic acid, vitamin B12, homocysteine
and fatty acid levels
As expected, folic acid supplementation (EFB and EFBD)
increased (p,0.05) plasma folic acid as compared to controls
(Table 2). Similarly animals fed a vitamin B12 deficient diet had
lower (p,0.05) plasma vitamin B12 levels as compared to control.
Homocysteine concentrations were comparable between groups.
(Table 2)
Placental fatty acid levels
DHA levels were significantly (p,0.05) reduced in both the
NFBD and EFBD groups as compared to control (Table 3). In
contrast, supplementation with omega 3 fatty acids improved
(p,0.01) DHA and omega 3 fatty acid levels but reduced
arachidonic acid and omega 6 fatty acid (p,0.05) levels in
NFBDO as well as EFBDO groups. MUFA (mono-unsaturated
fatty acid) levels in the NFBDO group and EFBDO were reduced
as compared to NFBD and EFBD groups respectively (p,0.01 for
both).
Placental global methylation levels
Global DNA methylation levels in placental tissue were reduced
in the EFBD group as compared to control and NFBD group
(p,0.05). In contrast, in the EFBDO group DNA methylation
levels were higher (p,0.05) as compared to the EFBD and were
comparable to control (Fig. 2).
Discussion
This is the first report that has examined the effect of two levels
(normal and excess) of folic acid both in presence and absence of
vitamin B12 deficiency on global DNA methylation levels in the
placenta. Our results indicate 1) altered levels of maternal
micronutrients did not influence homocysteine concentrations 2)
placental DHA levels were reduced in the vitamin B12 deficient
groups 3) excess maternal folic acid supplementation in the absence
of vitamin B12 results in reduced global DNA methylation levels 4)
when omega 3 fatty acids were supplemented to the diet with excess
maternal folic acid and vitamin B12 deficiency, DNA methylation
levels revert back to the levels observed in the control group.
Our findings for the first time suggest that maternal vitamin B12
deficiency, both at normal and excess folic acid levels reduces
placental DHA concentrations although mechanisms need to be
understood. We and others have previously reported that folic acid
Table 2. Dam plasma folate, vitamin B12 and homocysteine levels.
Control (n=8) NFBD (n=8) EFB (n=7) EFBD (n=8) NFBDO (n=7) EFBDO (n=6)
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Folic acid (ng/ml) 26.00 14.48 23.50 12.32 69.86
** 8.47 73.88
** 3.36 34.43 16.05 71.00
** 4.43
Vitamin B12 (pg/ml) 287.63 56.33 192.29
** 28.53 274.00 70.58 188.25
**{{ 33.01 182.00
** 17.52 181.00
**{{11 25.63
Homocysteine
(mmoles/L)
7.67 1.24 7.53 1.42 6.89 1.48 7.24 1.35 8.97 1.34 7.58
# 2.21
**P,0.01 when compared to control;
{P,0.05,
{{P,0.01 when compared to NFBD;
{P,0.05,
{{P,0.01 when compared to EFB;
11P,0.01 when compared to EFBD.
AA: Arachidonic acid; Control: Normal folate, normal B12, NFBD: normal folate, B12 deficient, NFBDO: normal folate, B12 deficient, omega 3 supplemented, EFB: Excess
folate, normal B12, EFBD: Excess folate, B12 deficient, EFBDO: Excess folate, B12 deficient, omega 3 supplemented.
doi:10.1371/journal.pone.0017706.t002
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vitamin B12 deficiency either results in a virtual deficiency of folic
acid thereby affecting methyl group supply or PEMT may be
epigenetically altered leading to reduced expression affecting the
conversion of PE-DHA (phosphatidyl ethanolamine-DHA) to PC-
DHA (phosphatidyl choline-DHA) resulting in lower DHA levels
in placenta. The PC/PE ratio also modulates the activity of Delta-
5 and Delta-6 desaturases involved in omega 3 and omega 6
PUFA synthesis [31].
Reports suggest that an imbalance between folate and vitamin
B12 during pregnancy could influence imprinting in the embryo,
perhaps by an effect on DNA methylation since folates are co-
factors and co-substrates for biological methylation and nucleic
acid synthesis and also function as regulatory molecules [32]. DNA
methylation patterns which are largely established in-utero, induce
stable changes in gene expression that may be sustained
throughout the life span of an individual [33]. Associations of
homocysteine with global methylation patterns are not well
Table 3. Placental fatty acid levels in different treatment groups.
Control(n=15) NFBD(n=16) EFB (n=16) EFBD (n=15) NFBDO (n=16) EFBDO (n=14)
mean SD mean SD mean SD mean SD mean SD mean SD
Alpha linolenic acid 1.86 4.72 0.62 0.19 0.40
* 0.26 2.13
{{ 4.15 1.62 3.75 1.73 4.47
Linoleic acid 12.77 1.39 12.01 1.30 12.19 1.73 13.25
{{{ 1.20 11.51
** 1.80 10.89
**{{{11 0.97
Docosahexaenoic acid 3.73 0.88 2.94
* 0.99 3.48 0.64 2.76
**{ 0.57 6.75
**{{ 2.17 7.72
**{{11 2.07
Arachidonic acid 17.98 2.07 17.29 2.22 17.71 1.76 17.33 2.10 12.85
**{{ 3.35 12.49
**{{11 1.58
Omega 3 fatty acids 5.68 4.53 3.68
** 1.09 4.15 0.71 4.98 3.95 9.93
**{{ 3.28 11.68
**{{11 3.76
Omega 6 fatty acids 31.86 3.32 30.49 2.90 31.17 2.88 31.60 2.85 27.35
**{{ 4.49 26.97
**{{11 1.82
Monounsaturated fatty acids 13.85 1.80 15.08 1.78 13.25 3.18 15.01
{ 3.05 12.38
{{ 3.49 12.34
11 2.72
Saturated fatty acids 40.61 4.82 43.58 2.39 36.80
* 6.51 41.59
{ 4.71 44.27
* 4.61 42.97
{ 4.40
*P,0.05,
**P,0.01 when compared to control;
{P,0.05,
{{P,0.01 when compared to NFBD;
{P,0.05,
{{P,0.01 when compared to EFB;
11P,0.01 when compared to EFBD.
Control: Normal folate, normal B12, NFBD: normal folate, B12 deficient, NFBDO: normal folate, B12 deficient, omega 3 supplemented, EFB: Excess folate, normal B12, EFBD:
Excess folate, B12 deficient, EFBDO: Excess folate, B12 deficient, omega 3 supplemented.
doi:10.1371/journal.pone.0017706.t003
Figure 2. Percent global DNA methylation in Wistar rat placenta. *p,0.05 when compared to control (Normal folate, normal B12);
{ p,0.05
when compared to NFBD (Normal folate, B12 deficient);
{p,0.05 when compared to EFBD (Excess folate, B12 deficient), NFBDO: normal folate, B12
deficient, omega 3 supplemented, EFB: Excess folate, normal B12 ; EFBDO: Excess folate, B12 deficient, omega 3 supplemented.
doi:10.1371/journal.pone.0017706.g002
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reported to be associated with reduced DNA methylation potential
by some [34,35], while others have reported increased DNA
methylation [36,37]. On the other hand, recently Bromberg et al
have reported no association between homocysteine and DNA
methylation [38]. Our findings also suggest that homocysteine
concentrations may not be the only determinant of global
methylation levels in the placenta.
Low folic acid status is often associated with impaired DNA
methylation [39], affecting gene expression in complex ways
[40–43], however it is not known whether excess folic acid might
have any adverse effects on these functions. In a recent study, Min
et al.[44] have also shown that folic acid supplementation in
vitamin B12 deficient rat did not alter hepatic SAM and SAH (S-
adenosyl homocysteine) concentrations and DNA methylation. In
our study, at normal folic acid there was no change in placental
global DNA methylation levels. However, in contrast at excess
folic acid levels in the absence of vitamin B12 it was lower as
compared to control. It has been reported that effect of folate
status on DNA methylation in animals and humans is tissue-, site-,
and gene-specific [40,43]. Our results suggest that it may be the
ratio of folic acid and vitamin B12 that may play an important role
in determining global DNA methylation.
Evidence from in vivo studies has not clearly established a link
between vitamin B12 and DNA methylation. However it has been
demonstrated in the animal model that a B12 deficient diet,
disturbs normal homeostasis of one-carbon metabolism in the
colonic mucosa and results in diminished genomic DNA
methylation and increased uracil misincorporation in DNA [45].
Further, it has recently been shown that gene expression patterns
change under B12 deficient conditions and are recovered by
dietary methionine supplementation to B12 deficient rats [46].
For the first time this study has shown that supplementation
with omega 3 fatty acids in excess folic acid and vitamin B12
deficient group increased placental global DNA methylation to
control levels. During early development, there are two waves of
demethylation which are followed by a gradual increase in de novo
methylation in the embryonic and extraembryonic (which includes
the placenta) tissues [47]. Deficiencies of vitamin B12 or other
abnormalities within the one carbon cycle have been implicated in
the development of such placental diseases [48]. Our findings
suggest that placental maturation and development may be
hampered due to vitamin B12 deficiency and absence of DHA
leading to lower total global methylation (hypomethylation). DHA
is reported to play an important role in development and
maturation of vital tissues such as brain and placenta [49,50].
Our findings indicate that DHA supplementation restores
(increases) the global methylation levels to control levels suggesting
that that omega 3 fatty acids especially DHA plays an important
role in determining methylation levels in the placenta. Further, our
results are in line with previous studies in the rat model which have
demonstrated that supplementation with omega-3 fatty acids
during pregnancy [51] or post natal life [52] could prevent or limit
adverse outcomes of fetal programming. Further studies on gene-
specific methylation involved in placental growth and pathology
will throw light on the mechanisms to explain the current data.
The methodology for estimation of global methylation levels
used in this study takes into account methylation of all CpG’s
irrespective of their position in the genome (promoter and non-
promoter CpG). This is in concurrence with studies indicating that
CpG methylation in intragenic and intergenic regions are also
critical to gene expression [30]. Although this study has not
examined methylation at gene specific level, our lab has initiated
studies to examine the epigenetic changes occurring at genes
associated with one carbon metabolism. Understanding these
mechanisms may help in elucidating pathways associated with
adverse pregnancy outcomes. In conclusion, changes in maternal
micronutrients such as folate, vitamin B12 and omega-3 fatty acids
could alter the availability of these key metabolites of one carbon
cycle in the fetus, providing a direct link between maternal
nutrition and placental gene methylation.
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